Effect of endothelial dysfunction on the pathogenesis of urolithiasis in patients with metabolic syndrome.
Objective: The aim of the present prospective clinical study was to investigate the possible effect of endothelial dysfunction in urolithiasis. Methods: The study included 92 patients older than 18 years. The patients were divided into 4 groups with 23 patients each as group 1: metabolic sydrome (MetS) (-) stone disease (SD) (-), group 2: MetS (-) SD (+), group 3: MetS (+) SD (-) and group 4: MetS (+) SD (+). C-reactive protein, homocysteine, uric acid, and creatinine levels were evaluated between the groups. Endothelial (dys)function was evaluated based on the brachial artery flow-mediated dilation (FMD) measurement. Results: The mean age was 41.9 ± 10.2 (range, 18-62) years. Mean FMD value was 15.9 ± 18.2% (range, 24.0-68.5%). A strong significant difference was found between group 1 and 2 (p < .001); group 1 and 3 (p < .001) and group 1 and 4 (p < .001) with regard to FMD. Conclusion: These results suggest that endothelial dysfunction plays an important role in the pathogenesis of urolithiasis in patients with MetS.